American College of Radiology conducts a clinical trial of Improving Utilization of Lung Cancer Screening in Underserved PA Populations
Photo by Ani Kolleshi
American College of Radiology is starting a new clinical trial of Improving Utilization of Lung Cancer Screening in Underserved PA Populations.
This study is intended to assess the impact of a centralized outreach intervention that includes shared decision-making about lung cancer screening (LCS) in LCS-eligible primary care patients. The study's goal is to increase LCS rates compared to usual care and thus reduce lung cancer deaths.
The research team will select primary care practices included in areas where lung cancer mortality is high. An outreach registry of primary care patients obtaining care at participating practices who meet study eligibility criteria will be created from the electronic medical record. 500 primary care patients will be randomly selected for the Outreach Contact with Decision Counseling (OCDC) Group from this outreach registry. Patients targeted for inclusion in the study will have a scheduled primary care appointment 18-23 days after initial outreach contact.
Among the exclusion criteria are:
- Chest CT performed in the last 12 months before study initiation according to EMR
- Diagnosis of lung cancer indicated in the problem list in the EMR
- Primary language is not English
- Current cancer treatment or other qualifying diagnoses that would make outreach inappropriate (e.g., dementia, hearing disability)
The clinical trial started in March 2021 and will continue throughout May 2023.
Thomas Jefferson University is the collaborator in this study.
The contacts and locations are the Lehigh Valley Health Network, Allentown, Pennsylvania and Jefferson Health System, Philadelphia, Pennsylvania, United States.
For more details: https://ichgcp.net/clinical-trials-registry/NCT04806399
